...
首页> 外文期刊>Biological psychiatry >Rett-like Severe Encephalopathy Caused by a De?Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement
【24h】

Rett-like Severe Encephalopathy Caused by a De?Novo GRIN2B Mutation Is Attenuated by D-serine Dietary Supplement

机译:由de?Novo Grin2B突变引起的静态脑病被D-丝氨酸膳食补充剂衰减

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract Background N -Methyl-D-aspartate receptors (NMDARs) play pivotal roles in synaptic development, plasticity, neural survival, and cognition. Despite recent reports describing the genetic association between de novo mutations of NMDAR subunits and severe psychiatric diseases, little is known about their pathogenic mechanisms and potential therapeutic interventions. Here we report a case study of a 4-year-old Rett-like patient with severe encephalopathy carrying a missense de novo mutation in GRIN2B (p.P553T) coding for the GluN2B subunit of NMDAR. Methods We generated a dynamic molecular model of mutant GluN2B-containing NMDARs. We expressed the mutation in cell lines and primary cultures, and we evaluated the putative morphological, electrophysiological, and synaptic plasticity alterations. Finally, we evaluated D-serine administration as a therapeutic strategy and translated it to the clinical practice. Results Structural molecular modeling predicted a reduced pore size of mutant NMDARs. Electrophysiological recordings confirmed this prediction and also showed gating alterations, a reduced glutamate affinity associated with a strong decrease of NMDA-evoked currents. Moreover, GluN2B(P553T)-expressing neurons showed decreased spine density, concomitant with reduced NMDA-evoked currents and impaired NMDAR-dependent insertion of GluA1 at stimulated synapses. Notably, the naturally occurring coagonist D-serine was able to attenuate hypofunction of GluN2B(p.P553T)-containing NMDARs. Hence, D-serine dietary supplementation was initiated. Importantly, the patient has shown remarkable motor, cognitive, and communication improvements after 17?months of D-serine dietary supplementation. Conclusions Our data suggest that hypofunctional NMDARs containing GluN2B(p.P553T) can contribute to Rett-like encephalopathy and that their potentiation by D-serine treatment may underlie the associated clinical improvement.
机译:摘要背景N-甲基-D-天冬氨酸受体(NMDARS)在突触发育,可塑性,神经生存和认知中起着枢轴作用。尽管最近的报告描述了NMDAR亚基和严重的精神疾病的遗传关联,但对其致病机制和潜在的治疗干预措施很少。在这里,我们举报了对具有严重脑病的4岁的Rett样患者进行了患有鼠标的麦克兰2B(P.P553T)中的脑电图的严重脑病的患者。方法生成含突变GLUN2B的NMDAR的动态分子模型。我们表达了细胞系和原发性培养中的突变,我们评估了推定的形态学,电生理学和突触可塑性改变。最后,我们评估了D-丝氨酸管理作为治疗策略,并将其转化为临床实践。结果结构分子建模预测突变肿瘤的孔径降低。电生理记录证实了这种预测,并且还显示出种子改变,降低谷氨酸亲和力,与NMDA诱发电流的强度降低相关。此外,GLUN2B(P553T) - 表达神经元显示出脊柱密度降低,伴随着降低的NMDA诱发电流,并在刺激的突触处损害了GLUA1的NMDAR依赖性插入。值得注意的是,天然存在的常一致性D-丝氨酸能够衰减GLUN2B(P.P553T)的肿瘤NMDARS的紊乱。因此,启动了D-丝氨酸膳食补充剂。重要的是,患者在17个月的D-丝氨酸膳食补充剂后显示出显着的电动机,认知和通信改善。结论我们的数据表明,含有GLUN2B(P.P553T)的多官能NMDAR可以有助于静脉曲张化病变,并通过D-丝氨酸处理的增强可能提出相关的临床改善。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号